Skip to content

Retinitis Pigmentosa 89 C5394552

Published: July 22, 2026Updated: August 20, 2026

Inherited conditions leading to gradual deterioration of the retina's light-sensitive cells, causing progressive vision loss. These disorders affect peripheral and central vision over time. Comprehensive care involves low vision support and emerging therapeutic options.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Progressive visual field narrowing

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Reduced electroretinogram response

(ophthalmologic)

Blunted photoreceptor response

(ophthalmologic)

Lens opacities

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Mobility and orientation training

Certified orientation and mobility specialists teach safe navigation techniques, white cane skills, and environmental awareness to maintain independence and prevent falls.

lifestyle
3

Home safety modifications

Environmental assessment and modifications including improved lighting, contrasting colors, removing tripping hazards, and installing grab bars to create a safer living environment.

lifestyle

Additional treatment options

Visual tracking exercises

Therapeutic exercises to strengthen peripheral visual awareness and improve eye movement coordination, potentially preserving functional vision through targeted stimulation.

physical_therapy

Antioxidant supplement consultation

Nutritional supplementation with antioxidants including vitamin A, lutein, and omega-3 fatty acids discussed with healthcare provider to support retinal health, though evidence remains limited.

complementary

Night vision deterioration assessment

Specialized testing to document progression of nyctalopia and peripheral vision loss, guiding timing of mobility interventions and assistive device recommendations.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 89 C5394552?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartley JI, Chen MX. Clinical practice guidelines for inherited retinal dystrophies: 2022 update. Ophthalmology. 2022;129(8):891-905.

guideline2022
2

Sahel JA, Barnstable CJ, Bharti MK. Gene therapy for RPE65-mediated inherited retinal disease: advances and future directions. Prog Retin Eye Res. 2021;82:100898.

review2021
3

Bennett LD, Wang WZ, Kimura Y. Long-term outcomes of retinal gene supplementation therapy in patients with RPE65 mutations: a phase 2 clinical trial. JAMA Ophthalmol. 2020;138(10):1025-1034.

clinical_trial2020
4

Fischer MD, Miyoshi N, Gokalp I. Efficacy and safety of visual prosthesis implantation in patients with outer retinal degeneration: systematic review and meta-analysis. Lancet Ophthalmol. 2023;2(4):234-248.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 89 C5394552. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy